---
title: CROs offering LC-MS Bioanalysis (Small Molecule) with Peptide
path: /explore/lc-ms-bioanalysis/peptide
companies_count: 14
---

# CROs offering LC-MS Bioanalysis (Small Molecule) with Peptide

14 published CROs match LC-MS Bioanalysis (Small Molecule) and Peptide.

Locations in this set include United States, China, Denmark, India, United Kingdom, and 30 countries.

Capabilities that show up most often in this set: Bioanalysis, In Vivo PK / PD Studies, In Vitro ADME / DMPK, In Vitro Pharmacology, and In Vivo Efficacy Models.

## Matching companies

- [Aliri Bioanalysis](/companies/aliribio)
  - Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise.
- [Amador Bioscience](/companies/amadorbioscience)
  - Amador Bioscience provides bioanalysis and biomarker services, including LCMS, immunoassays, flow cytometry, and immunogenicity testing, alongside clinical pharmacology modeling and regulatory affairs support. Its labs are GLP compliant, and its teams work across the US, China, and Europe.
- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [Biotest Facility](/companies/bioxpedia)
  - Danish CRO offering in vivo models, proteomics, transcriptomics, biomarker discovery, and bioinformatics to support biotech and pharma research from concept to validated data.
- [Certara](/companies/certara)
  - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
- [ChemPartner](/companies/chempartner)
  - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
- [Pharma Inventor](/companies/pharmainventor)
  - Vancouver-based preclinical drug discovery CRO offering medicinal chemistry, custom synthesis, LC-MS/MS bioanalysis, high-throughput screening and ADC development for pharma and biotech teams. Lists 6,000+ sq ft of research facilities and in-house 400 MHz NMR.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Protheragen](/companies/obesityscientific)
  - Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.
- [Selvita](/companies/selvita)
  - Selvita is an integrated drug discovery and development service provider offering comprehensive solutions from target validation through preclinical candidate nomination and clinical manufacturing, with expertise in small molecules, antibodies, and protein degraders.
- [Swiss BioQuant AG](/companies/swissbioquant)
  - Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [Tigermed](/companies/tigermedgrp)
  - Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
- [WuXi AppTec](/companies/wuxiapptec)
  - Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.